{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T07:12:45Z","timestamp":1790233965486,"version":"4.1.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Aldosterone (Aldo) contributes to mitochondrial dysfunction and cardiac oxidative stress. Using a proteomic approach, A-kinase anchor protein (AKAP)-12 has been identified as a down-regulated protein by Aldo in human cardiac fibroblasts. We aim to characterize whether AKAP-12 down-regulation could be a deleterious mechanism which induces mitochondrial dysfunction and oxidative stress in cardiac cells. Aldo down-regulated AKAP-12 via its mineralocorticoid receptor, increased oxidative stress and induced mitochondrial dysfunction characterized by decreased mitochondrial-DNA and Peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1\u03b1) expressions in human cardiac fibroblasts. CRISPR\/Cas9-mediated knock-down of AKAP-12 produced similar deleterious effects in human cardiac fibroblasts. CRISPR\/Cas9-mediated activation of AKAP-12 blunted Aldo effects on mitochondrial dysfunction and oxidative stress in human cardiac fibroblasts. In Aldo-salt-treated rats, cardiac AKAP-12, mitochondrial-DNA and PGC-1\u03b1 expressions were decreased and paralleled increased oxidative stress. In myocardial biopsies from patients with aortic stenosis (AS, n\u2009=\u200926), AKAP-12, mitochondrial-DNA and PGC-1\u03b1 expressions were decreased as compared to Controls (n\u2009=\u200913). Circulating Aldo levels inversely correlated with cardiac AKAP-12. PGC-1\u03b1 positively associated with AKAP-12 and with mitochondrial-DNA. Aldo decreased AKAP-12 expression, impairing mitochondrial biogenesis and increasing cardiac oxidative stress. AKAP-12 down-regulation triggered by Aldo may represent an important event in the development of mitochondrial dysfunction and cardiac oxidative stress.<\/jats:p>","DOI":"10.1038\/s41598-018-25068-6","type":"journal-article","created":{"date-parts":[[2018,4,25]],"date-time":"2018-04-25T09:41:18Z","timestamp":1524649278000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Aldosterone Impairs Mitochondrial Function in Human Cardiac Fibroblasts via A-Kinase Anchor Protein 12"],"prefix":"10.1038","volume":"8","author":[{"given":"Jaime","family":"Ibarrola","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Sadaba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernesto","family":"Martinez-Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amaia","family":"Garcia-Pe\u00f1a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Arrieta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia","family":"Alvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amaya","family":"Fern\u00e1ndez-Celis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia","family":"Gainza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Cachofeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrique","family":"Santamaria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joaquin","family":"Fernandez-Irigoyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederic","family":"Jaisser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Lopez-Andres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,5,1]]},"reference":[{"key":"25068_CR1","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1146\/annurev.physiol.010908.163119","volume":"71","author":"MB Hock","year":"2009","unstructured":"Hock, M. B. & Kralli, A. Transcriptional control of mitochondrial biogenesis and function. Annu. Rev. Physiol. 71, 177\u2013203 (2009).","journal-title":"Annu. Rev. Physiol."},{"key":"25068_CR2","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1097\/HCO.0b013e328333d3d6","volume":"25","author":"T Aiba","year":"2010","unstructured":"Aiba, T. & Tomaselli, G. F. Electrical remodeling in the failing heart. Curr. Opin. Cardiol. 25, 29\u201336 (2010).","journal-title":"Curr. Opin. Cardiol."},{"key":"25068_CR3","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1038\/sj.cdd.4402145","volume":"14","author":"L Pellegrini","year":"2007","unstructured":"Pellegrini, L. & Scorrano, L. A cut short to death: Parl and Opa1 in the regulation of mitochondrial morphology and apoptosis. Cell Death Differ. 14, 1275\u201384 (2007).","journal-title":"Cell Death Differ."},{"key":"25068_CR4","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1097\/01.ASN.0000019772.17954.F8","volume":"13","author":"K Yamagata","year":"2002","unstructured":"Yamagata, K. et al. Mitochondrial DNA mutations in focal segmental glomerulosclerosis lesions. J. Am. Soc. Nephrol. 13, 1816\u201323 (2002).","journal-title":"J. Am. Soc. Nephrol."},{"key":"25068_CR5","doi-asserted-by":"publisher","first-page":"3587","DOI":"10.1172\/JCI25151","volume":"115","author":"K Morino","year":"2005","unstructured":"Morino, K. et al. Reduced mitochondrial density and increased IRS-1 serine phosphorylation in muscle of insulin-resistant offspring of type 2 diabetic parents. J. Clin. Invest. 115, 3587\u20133593 (2005).","journal-title":"J. Clin. Invest."},{"key":"25068_CR6","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.1161\/CIRCULATIONAHA.109.906610","volume":"121","author":"SB Ong","year":"2010","unstructured":"Ong, S. B. et al. Inhibiting Mitochondrial Fission Protects the Heart Against Ischemia\/Reperfusion Injury. Circulation 121, 2012\u20132022 (2010).","journal-title":"Circulation"},{"key":"25068_CR7","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1016\/j.addr.2009.06.006","volume":"61","author":"J Vi\u00f1a","year":"2009","unstructured":"Vi\u00f1a, J. et al. Mitochondrial biogenesis in exercise and in ageing\u2606. Adv. Drug Deliv. Rev. 61, 1369\u20131374 (2009).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"25068_CR8","doi-asserted-by":"publisher","first-page":"272","DOI":"10.21037\/cdt.2017.03.04","volume":"7","author":"R De Vecchis","year":"2017","unstructured":"De Vecchis, R. & Ariano, C. Differential efficacy profile of aldosterone receptor antagonists, depending on the type of chronic heart failure, whether with reduced or preserved left ventricular ejection fraction\u2014results of a meta-analysis of randomized controlled trials. Cardiovasc. Diagn. Ther. 7, 272\u2013287 (2017).","journal-title":"Cardiovasc. Diagn. Ther."},{"key":"25068_CR9","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1161\/HYPERTENSIONAHA.115.05876","volume":"66","author":"E Mart\u00ednez-Mart\u00ednez","year":"2015","unstructured":"Mart\u00ednez-Mart\u00ednez, E. et al. Galectin-3 Blockade Inhibits Cardiac Inflammation and Fibrosis in Experimental Hyperaldosteronism and HypertensionNovelty and Significance. Hypertension 66, 767\u2013775 (2015).","journal-title":"Hypertension"},{"key":"25068_CR10","doi-asserted-by":"publisher","first-page":"1928","DOI":"10.1016\/j.cellsig.2015.07.001","volume":"27","author":"NK Somanna","year":"2015","unstructured":"Somanna, N. K. et al. Aldosterone-induced cardiomyocyte growth, and fibroblast migration and proliferation are mediated by TRAF3IP2. Cell. Signal. 27, 1928\u20131938 (2015).","journal-title":"Cell. Signal."},{"key":"25068_CR11","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1016\/S0002-9440(10)64454-9","volume":"161","author":"Y Sun","year":"2002","unstructured":"Sun, Y. et al. Aldosterone-Induced Inflammation in the Rat Heart. Am. J. Pathol. 161, 1773\u20131781 (2002).","journal-title":"Am. J. Pathol."},{"key":"25068_CR12","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s00395-013-0359-8","volume":"108","author":"AD Hafstad","year":"2013","unstructured":"Hafstad, A. D., Nabeebaccus, A. A. & Shah, A. M. Novel aspects of ROS signalling in heart failure. Basic Res. Cardiol. 108, 359 (2013).","journal-title":"Basic Res. Cardiol."},{"key":"25068_CR13","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.1016\/j.ajpath.2011.01.029","volume":"178","author":"C Zhu","year":"2011","unstructured":"Zhu, C. et al. Mitochondrial dysfunction mediates aldosterone-induced podocyte damage: a therapeutic target of PPAR\u03b3. Am. J. Pathol. 178, 2020\u201331 (2011).","journal-title":"Am. J. Pathol."},{"key":"25068_CR14","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.freeradbiomed.2012.03.015","volume":"53","author":"Y Yuan","year":"2012","unstructured":"Yuan, Y. et al. Mitochondrial dysfunction accounts for aldosterone-induced epithelial-to-mesenchymal transition of renal proximal tubular epithelial cells. Free Radic. Biol. Med. 53, 30\u201343 (2012).","journal-title":"Free Radic. Biol. Med."},{"key":"25068_CR15","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1161\/CIRCRESAHA.111.262899","volume":"111","author":"A Perino","year":"2012","unstructured":"Perino, A., Ghigo, A., Scott, J. D. & Hirsch, E. Anchoring proteins as regulators of signaling pathways. Circ. Res. 111, 482\u201392 (2012).","journal-title":"Circ. Res."},{"key":"25068_CR16","doi-asserted-by":"publisher","first-page":"E384","DOI":"10.1152\/ajpendo.00175.2014","volume":"307","author":"C Zeng","year":"2014","unstructured":"Zeng, C. et al. AKAP150 mobilizes cPKC-dependent cardiac glucotoxicity. Am. J. Physiol. Endocrinol. Metab. 307, E384\u201397 (2014).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"25068_CR17","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1093\/cvr\/cvq155","volume":"88","author":"C Perrino","year":"2010","unstructured":"Perrino, C. et al. AKAP121 downregulation impairs protective cAMP signals, promotes mitochondrial dysfunction, and increases oxidative stress. Cardiovasc. Res. 88, 101\u2013110 (2010).","journal-title":"Cardiovasc. Res."},{"key":"25068_CR18","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.yjmcc.2010.11.002","volume":"50","author":"RS Adluri","year":"2011","unstructured":"Adluri, R. S. et al. Thioredoxin 1 enhances neovascularization and reduces ventricular remodeling during chronic myocardial infarction: A study using thioredoxin 1 transgenic mice. J. Mol. Cell. Cardiol. 50, 239\u2013247 (2011).","journal-title":"J. Mol. Cell. Cardiol."},{"key":"25068_CR19","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.jprot.2017.07.011","volume":"166","author":"E Mart\u00ednez-Mart\u00ednez","year":"2017","unstructured":"Mart\u00ednez-Mart\u00ednez, E. et al. Differential proteomics reveals S100-A11 as a key factor in aldosterone-induced collagen expression in human cardiac fibroblasts. J. Proteomics 166, 93\u2013100 (2017).","journal-title":"J. Proteomics"},{"key":"25068_CR20","doi-asserted-by":"publisher","first-page":"435","DOI":"10.3109\/10799893.2015.1122042","volume":"36","author":"CM Araujo","year":"2016","unstructured":"Araujo, C. M. et al. Rapid effects of aldosterone in primary cultures of cardiomyocytes \u2013 do they suggest the existence of a membrane-bound receptor? J. Recept. Signal Transduct. 36, 435\u2013444 (2016).","journal-title":"J. Recept. Signal Transduct."},{"key":"25068_CR21","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1038\/sj.embor.7401062","volume":"8","author":"JT Cribbs","year":"2007","unstructured":"Cribbs, J. T. & Strack, S. Reversible phosphorylation of Drp1 by cyclic AMP-dependent protein kinase and calcineurin regulates mitochondrial fission and cell death. EMBO Rep. 8, 939\u2013944 (2007).","journal-title":"EMBO Rep."},{"key":"25068_CR22","first-page":"5644","volume":"61","author":"W Xia","year":"2001","unstructured":"Xia, W., Unger, P., Miller, L., Nelson, J. & Gelman, I. H. The Src-suppressed C kinase substrate, SSeCKS, is a potential metastasis inhibitor in prostate cancer. Cancer Res. 61, 5644\u201351 (2001).","journal-title":"Cancer Res."},{"key":"25068_CR23","doi-asserted-by":"publisher","first-page":"e94695","DOI":"10.1371\/journal.pone.0094695","volume":"9","author":"J-H Cha","year":"2014","unstructured":"Cha, J.-H. et al. AKAP12 Mediates Barrier Functions of Fibrotic Scars during CNS Repair. PLoS One 9, e94695 (2014).","journal-title":"PLoS One"},{"key":"25068_CR24","doi-asserted-by":"publisher","first-page":"4472","DOI":"10.1523\/JNEUROSCI.5368-06.2007","volume":"27","author":"YK Choi","year":"2007","unstructured":"Choi, Y. K. et al. AKAP12 Regulates Human Blood-Retinal Barrier Formation by Downregulation of Hypoxia-Inducible Factor-1. J. Neurosci. 27, 4472\u20134481 (2007).","journal-title":"J. Neurosci."},{"key":"25068_CR25","doi-asserted-by":"publisher","DOI":"10.3858\/emm.2012.44.3.017","volume":"44","author":"H-B Kwon","year":"2012","unstructured":"Kwon, H.-B. et al. AKAP12 regulates vascular integrity in zebrafish. Exp. Mol. Med. 44, 225 (2012).","journal-title":"Exp. Mol. Med."},{"key":"25068_CR26","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/labinvest.2011.199","volume":"92","author":"B Burnworth","year":"2012","unstructured":"Burnworth, B. et al. SSeCKS sequesters cyclin D1 in glomerular parietal epithelial cells and influences proliferative injury in the glomerulus. Lab. Investig. 92, 499\u2013510 (2012).","journal-title":"Lab. Investig."},{"key":"25068_CR27","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1096\/fj.13-238741","volume":"28","author":"T Weissm\u00fcller","year":"2014","unstructured":"Weissm\u00fcller, T. et al. HIF-dependent regulation of AKAP12 (gravin) in the control of human vascular endothelial function. FASEB J. 28, 256\u201364 (2014).","journal-title":"FASEB J."},{"key":"25068_CR28","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s12265-017-9734-4","volume":"10","author":"V Selvaraju","year":"2017","unstructured":"Selvaraju, V. et al. Regulation of A-Kinase-Anchoring Protein 12 by Heat Shock Protein A12B to Prevent Ventricular Dysfunction Following Acute Myocardial Infarction in Diabetic Rats. J. Cardiovasc. Transl. Res. 10, 209\u2013220 (2017).","journal-title":"J. Cardiovasc. Transl. Res."},{"key":"25068_CR29","doi-asserted-by":"publisher","first-page":"10086","DOI":"10.1073\/pnas.0603615103","volume":"103","author":"Z Arany","year":"2006","unstructured":"Arany, Z. et al. Transverse aortic constriction leads to accelerated heart failure in mice lacking PPAR- coactivator 1. Proc. Natl. Acad. Sci. 103, 10086\u201310091 (2006).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"25068_CR30","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1172\/JCI24405","volume":"115","author":"JM Huss","year":"2005","unstructured":"Huss, J. M. & Kelly, D. P. Mitochondrial energy metabolism in heart failure: a question of balance. J. Clin. Invest. 115, 547\u2013555 (2005).","journal-title":"J. Clin. Invest."},{"key":"25068_CR31","first-page":"622","volume":"16","author":"O Fabregat-Andres","year":"2016","unstructured":"Fabregat-Andres, O. et al. mRNA PGC-1\u03b1 levels in blood samples reliably correlates with its myocardial expression: study in patients undergoing cardiac surgery. Anatol. J. Cardiol. 16, 622\u2013629 (2016).","journal-title":"Anatol. J. Cardiol."},{"key":"25068_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-12305-7","volume":"7","author":"E Mart\u00ednez-Mart\u00ednez","year":"2017","unstructured":"Mart\u00ednez-Mart\u00ednez, E. et al. Differential Proteomics Identifies Reticulocalbin-3 as a Novel Negative Mediator of Collagen Production in Human Cardiac Fibroblasts. Sci. Rep. 7, 12192 (2017).","journal-title":"Sci. Rep."},{"key":"25068_CR33","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1161\/ATVBAHA.112.300569","volume":"33","author":"L Calvier","year":"2013","unstructured":"Calvier, L. et al. Galectin-3 Mediates Aldosterone-Induced Vascular Fibrosis. Arterioscler. Thromb. Vasc. Biol. 33, 67\u201375 (2013).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"25068_CR34","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.jchf.2014.08.002","volume":"3","author":"L Calvier","year":"2015","unstructured":"Calvier, L. et al. The impact of galectin-3 inhibition on aldosterone-induced cardiac and renal injuries. JACC. Heart Fail. 3, 59\u201367 (2015).","journal-title":"JACC. Heart Fail."},{"key":"25068_CR35","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1042\/CS20170145","volume":"131","author":"V Arrieta","year":"2017","unstructured":"Arrieta, V. et al. A role for galectin-3 in the development of early molecular alterations in short-term aortic stenosis. Clin. Sci. (Lond). 131, 935\u2013949 (2017).","journal-title":"Clin. Sci. (Lond)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-25068-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-25068-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-25068-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T04:46:54Z","timestamp":1671598014000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-25068-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,1]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["25068"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-25068-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,1]]},"assertion":[{"value":"2 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"6801"}}